Global Mouth Ulcer Treatment Market Report and Forecast 2024-2032

Global Mouth Ulcer Treatment Market Outlook

The global mouth ulcer treatment market size was estimated to be worth USD 1.73 billion in 2023. The market is expected to rise at a growth rate of 3.9% in the forecast period of 2024-2032. By 2032, the market value is anticipated to be worth USD 2.44 billion. The rising awareness of oral hygiene and the growing geriatric population are driving market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Mouth Ulcers Insights: Causes, Diagnosis, and Treatment

A mouth ulcer is a disorder associated with oral hygiene causing sores and lesions in the lips, palate, gums, and inner cheeks. Mouth ulcers are also called canker sores or aphthous ulcers.

Mouth ulcers are one of the most common diseases affecting nearly 20 per cent of the population at one point. The signs and symptoms of mouth ulcers are visible and appear as red, white, grey, or yellow sores in the mouth or around the lips. Other symptoms include light to moderate pain, increased soreness, swelling, and difficulty, while eating and brushing.

The exact cause of mouth ulcers is unknown but is set to be triggered by several factors including minor tissue injury, allergic reaction, orthodontic braces, hormonal changes, bacterial, viral or fungal infections, vitamin deficiencies, stress and lack of sleep.

Mouth ulcers are diagnosed with the help of visual examination and in severe cases, with the incorporation of blood tests to assess the levels of vitamins and minerals. Mouth ulcers are generally treated with the help of topical treatments including steroid ointments, antiseptic gels, and medicated mouth rinses.

In very rare cases, the mouth soar may turn into a chronic condition called oral cancer, which is visible above or below the tongue.

According to this study, the mouth ulcer treatment market can be categorised into the following segments:

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Drug Class

• Analgesics and Corticosteroids

• Antihistamines

• Antimicrobials

• Anaesthetics

• Others

Market Breakup by Formulation Type

• Sprays

• Mouthwashes

• Gels

• Lozenges

• Others

Market Breakup by Indication Type

• Aphthous Stomatitis

• Oral Lichen Planus

• Others

Market Breakup by Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Market Breakup by Region

• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Mouth Ulcer Treatment Market Scenario

The mouth ulcer treatment market is primarily driven by the rising prevalence of disorders associated with oral hygiene. These disorders are increased with the rise in the consumption of tobacco and other products and smoking cessation. According to reports by the National Library of Medicine, the prevalence rate of oral ulcers was estimated to be 9% in children, which is expected to rise in the forecast period.

The market is further driven by the increasing adoption of chemical-based toothpaste, growing oral hygiene awareness and a rising geriatric population. Additionally, the increasing demand for more advanced and effective treatments is also expected to bolster market growth. 

Other factors include poor oral hygiene, high stress, unhealthy lifestyles, oral infection or injury and lack of sleep are expected to increase the incidence of mouth ulcers. This is anticipated to fuel the mouth ulcer treatment market growth.

Mouthwash Segment Holds the Largest Share

Among the available formulations, the mouthwash segment is projected to dominate the market share. Medicated and non-medicated mouthwashes play a vital role in the management of canker sores by killing the microbial agents present in the mouth. The major key players and pharmaceutical companies are introducing several ayurvedic and flavoured mouthwashes which are expected to escalate the mouth ulcer treatment market demand during the forecast period.

North America to Dominate the Regional Markets

North America is expected to hold the largest share of the market owing to the rising incidence of ulcers, the availability of advanced technologies, and growing awareness. For example, MouthWatch, a key market player discovered an HD intra-oral camera in Las Vegas, which will assist the dentist in proper diagnosis and treatment. This will attribute to the market growth of this region.

Therapeutic Landscape

The treatment of mouth ulcers is simple and in maximum cases, can be done with the help of oral and topical medications along with several home remedies. The mouth ulcer treatment market is attributed to both preventative and therapeutic care. The treatment regimen depends on the type of ulcer and type of patient.

Mouth ulcers can be treated by non-steroidal anti-inflammatory drugs, such as ibuprofen and topical analgesics, like benzydamine mouthwash. These drugs are used for the management of light to moderate pain and provide temporary relief.

Certain types of mouthwashes, chlorhexidine, possess antiseptic properties, are used for the treatment of mouth ulcers. These help in killing microbial growth and thus prevent the further progression of infection. 

Topical gels, creams, and systemic steroids are also used to reduce inflammation. The antifungal drug is used to prevent oral candidiasis in patients taking prolonged steroids. For the treatment of recurrent ulcers, vitamin B12 has been found effective. Immunosuppressants are sometimes used for the treatment of severe mouth ulcers.

Further, preventative strategies are implemented to prevent mouth ulcer disease. This includes avoiding spicy foods, eating a well-balanced diet, and maintaining proper oral hygiene.

Clinical Trials Landscape

Manx Healthcare, a key market player has recently discovered Oral Soothe and Sore Throat 0.15% w/v mouthwash to manage the mouth and throat pain caused by various medical disorders, such as gum disease, mouth ulcers, dental surgery, and oral cancers.

GELX Oral Gel is a novel topical medication launched by US WorldMeds LLC for the treatment of oral pain associated with the disorders associated with the oral cavity. The gel is based on the zinc-taurine bioactive barrier therapy and will assist in the management of oral ulcers.

With extensive research and innovation, Implant Dentistry has launched a novel mouthwash rinse, Clinicept to protect oral mucosa and cavity from bacterial, fungal, and viral contamination.

Recently, ICPA Health Products has launched a novel medicated toothpaste, Trioplast for the treatment of mouth ulcers. Trioplast acts by lowering the swelling in the mouth by reducing the allergic reaction. This is expected to benefit the inflammatory diseases associated with the oral cavity.

The discovery of these novel therapeutic interventions will assist in the proper diagnosis and treatment of mouth ulcers. The novel product launches will facilitate the expansion of the  market.

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the mouth ulcers treatment market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Sunstar Suisse S.A.

• Reckitt Benckiser Group PLC

• Pfizer, Inc

• Blistex Inc

• Bristol-Myers Squibb Company

• GSK plc

• Church & Dwight Co., Inc.

• Colgate-Palmolive Company

• Dr Reddy’s Laboratories Ltd.

• Patterson Companies, Inc

• Prince Care Pharma Pvt Ltd.

• 3M

Key Highlights of the Report